Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 1998-2004

  Arroyo, María Victoria Alvarez ^a   Castilla, María Angeles ^a   Pacheco, Francisco Román González ^a   Tan, Dunyong ^a   Riesco, Amparo ^a   Casado, Santos ^a   Caramelo, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; ERYTHROPOIETIN; GENISTEIN; HERBIMYCIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; AORTA; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CATTLE; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FETAL CALF SERUM; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 0345055318     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M: Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87: 5978-5982, 1990
2. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91: 3974-3978, 1994
3. + ATPase activity. Acta Physiol Pharmacol Ther Latinoam 44: 1-10, 1994
4. Gogusev J, Zhu DL, Herembert T, Ammarguellat F, Marche P, Drucke T: Effect of erythropoietin on DNA synthesis, protooncogene expression and phospholipase C activity in rat vascular smooth muscle cells. Biochem Biophys Res Commun 199: 977-983, 1994
5. 2+ channels in glomerular mesangial cells [Abstract]. J Am Soc Nephrol 7: 1681, 1996
6. Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth cells. Atherosclerosis 78: 225-228, 1989
7. Carlini RG, Reyes AA, Rothstein M: Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47: 740-749, 1995
8. Fennie C, Cheng J, Dowbenko D, Young P, Lasky LA: CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors. Blood 86: 4454-4467, 1995
9. Goldberg MA, Schneider TJ: Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269: 4355-4359, 1994
10. Minchenko A, Salceda S, Bauer T, Caro J: Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40: 35-39, 1994
11. Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ: Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 268: C1362-C1368, 1995
12. Bikfalvi A, Han ZC: Angiogenic factors are hematopoietic growth factors and vice versa. Leukemia 8: 523-529, 1994
13. Metcalf D: Peptide factors, haemopoietic growth factors. Lancet 1: 825-827, 1989
14. Sawyer ST, Krantz SB, Goldwasser E: Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem 262: 5554-5562, 1987
15. Tsuda H, Huang RW, Takatsuki K: Role of protein phosphorylation in EPO-mediated early signal transduction: Analysis in the EPO-reactive cell line ELM-I-1 transfected with a c-fos-enhancer/promoter-luciferase reporter gene. Eur J Haematol 52: 207-215, 1994
16. Dai-CH, Krantz-S: Vanadate mimics the effect of stem cell factor on highly purified human erythroid burst-forming units in vitro, but not the effect of erythropoietin. Exp Hematol 20: 1055-1060, 1992
17. Ren HY, Komatsu N, Shimizu R, Okada K, Miura Y: Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line. J Biol Chem 269: 19633-19638, 1994
18. Haller H, Christel C, Dannenberg L, Thiele P, Lindschau C, Luft FC: Signal transduction of erythropoietin in endothelial cells. Kidney Int 50: 481-488, 1996
19. López Farré A, Riesco A, Espinosa G, Digiuni E, Cernadas MR, Alvarez V, Montón M, Rivas F, Gallego MJ, Egido J, Casado S, Caramelo C: Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88: 1166-1171, 1993
20. 2+ influx and protein tyrosine phosphorylation in endothelial cells is inhibited by herbimycin A. Biochem Biophys Res Commun 202: 1651-1656, 1994
21. Van Hionsbergh VW, Vermeer M, Koolwisk P, Grimbergen J, Koolstra T: Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells. Blood 84: 2984-2991, 1994
22. Korama B, De Juan E: Phosphotyrosine inhibition and control of vascular endothelial cell proliferation by genistein. Biochem Pharmacol 48: 809-818, 1994
23. +-adenosine triphosphatase on vascular action of arginine-vasopressin. J Clin Invest 86: 1241-1248, 1990
24. Caramelo C, Tsai P, Okada K, Briner V, Schrier RW: Mechanisms of rapid desensitization to arginine vasopressin in vascular smooth muscle cells. Am J Physiol 260: F44-F52, 1991
25. Sammbrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
26. Tuder RM, Flook BE, Voelker NF: Increased gene expression for VEGF and the VEGF receptor KDR/flk and flt-1 in lung exposed to acute or to chronic hypoxia: Modulate of gene expression by nitric oxide. J Clin Invest 95: 1798-1807, 1995
27. MacDougall IC, Neubert P, Coles GA: Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lancet 8635: 425-427, 1989
28. Neumayer HH, Brockmüller J, Fritschka E, Roots I, Scigalla P, Watemberg M: Pharmacokinetics of human recombinant erythropoietin after subcutaneous administration and in long term intravenous treatment in patients on maintenance hemodialysis. Contrib Nephrol 76: 131-142, 1989
29. Erslev AJ, Wilson J, Caro J: Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 109: 429-433, 1987
30. Mukhopadhyay D, Knebelman B, Cohen HT, Sukhatme VP: The Von Hippel-Lindau gene product interacts with Sp 1 to repress vascular endothelial growth promoter activity [Abstract]. J Am Soc Nephrol 7: 1662, 1996
31. Siemeister G, Weindel K, Mohrs K, Barleen B, Martiny-Banon G, Marme D: Evidence of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res 56: 2299-2301, 1996
32. Penta K, Sawyer ST: Erythropoietin induces the tyrosine phosphorylation, nuclear translocation and DNA binding of Stat 1 and Stat 5 in erythroid cells. J Biol Chem 270: 31282-31287, 1995
33. Yamamura Y, Noda M, Ikawa Y: Erythropoietin receptor and interleukin-2 receptor use different downstream signaling pathways for proliferation and apoptosis block. Leukemia 8[Suppl 1]: 5107-5110, 1994
34. Patterson C, Perrella MA, Endenge WO, Yoshizumi M, Lee ME, Haber E: Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells. J Clin Invest 89: 490-496, 1996
35. Devemy E, Billat C, Sartelet H, Martiny L, Haye B: Erythropoietin stimulates glycosyl phosphatidylinositol hydrolysis in rat erythroid progenitor cells and inositol phosphate glycan modulates their proliferation. Cell Signalling 6: 523-529, 1994